CYH Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $2.72
Market Cap (MRQ) $384M
P/E (TTM) 1.5
EPS (TTM) $1.86
Revenue (TTM) $11.98B
ROE (TTM) -16.7%
Debt/Equity (MRQ) -6.9
52W Range $2–$4

CYH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1
Ex-date Split Type
April 22, 2016 121-for-100 Forward

About Community Health Systems, Inc. Common Stock Company overview from Wikipedia

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

sectorHealth Care industryHealth Care employees44,000 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$12.48B
2016-12-31 → 2025-12-31
EPS$3.77
2016-12-31 → 2025-12-31
Free Cash Flow$208M
2016-12-31 → 2025-12-31
Net margin2.1%
2018-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend CYH 5Y avg Peer Median Verdict
P/E (TTM) 1.55Y avg ≈3.4 ≈3.4 15.5 Undervalued
P/S (TTM) 0.05Y avg ≈0.1 ≈0.1 1.2 Undervalued
P/B (MRQ) -0.35Y avg ≈-0.5 ≈-0.5 · ·
EV / EBITDA 7.15Y avg ≈13.1 ≈13.1 10.6 Undervalued
Price / FCF (TTM) -2.15Y avg ≈-0.8 ≈-0.8 · ·
Price / Cash Flow (TTM) 3.05Y avg ≈-1.6 ≈-1.6 6.5 Undervalued
EV / Revenue 0.85Y avg ≈1.0 ≈1.0 · ·
EV / FCF 50.55Y avg ≈-4.9 ≈-4.9 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

13
Ex-dateAmountCurrencyYield
Dec 13, 2012$0.21USD≈0.84%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 37.9%
Next Report Oct 21, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Jul 21, 2026 $-0.19 $-0.06 -201.1%
March 31, 2026 $-0.48 $-0.10 -387.3%
Dec. 31, 2025 $-0.01 $-0.10 90.5%
Sept. 30, 2025 $1.27 $-0.25 610.5%
June 30, 2025 $-0.05 $-0.11 52.6%
March 31, 2025 $-0.03 $-0.08 62.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 13
Metric Trend 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
Balance Sheet 26
Metric Trend 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
Cash Flow 13
Metric Trend 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
Profitability 7
Metric Trend 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
Liquidity & Solvency 4
Metric Trend 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
Efficiency 2
Metric Trend 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
Per Share 5
Metric Trend 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Growth Rates 9
Metric Trend 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
Valuation (TTM) 13
Metric Trend 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $12.48B $12.63B $12.49B $12.21B $12.37B
Operating Margin % 11.9% 4.3% 7.7% 6.7% 11.3%
Net Income $509M $-516M $-133M $46M $230M
Diluted EPS $3.77 $-3.90 $-1.02 $0.35 $1.76

Institutional owners (13F) 196 filers · $415.1M total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 196
Value held $415.1M
New positions 31
Exited positions 24
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
31 (+9 vs prior Q) 24 (+4 vs prior Q) 69 (+6 vs prior Q) 54 (-9 vs prior Q) +7.0M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
CastleKnight Management LP $44,704,517 13,384,586 10.77% Shares
Apollo Management Holdings, L.P. $39,610,817 11,859,526 9.54% Shares
BlackRock, Inc. $36,507,995 10,930,538 8.79% Shares
VANGUARD GROUP INC $28,605,579 9,168,455 6.89% Shares
Eversept Partners, LP $26,267,680 7,864,575 6.33% Shares
NOMURA HOLDINGS INC $22,388,384 6,703,109 5.39% Shares
VANGUARD CAPITAL MANAGEMENT LLC $17,668,370 5,289,931 4.26% Shares
WHITEBOX ADVISORS LLC $12,467,362 3,732,743 3.00% Shares
GEODE CAPITAL MANAGEMENT, LLC $10,582,352 3,167,702 2.55% Shares
STATE STREET CORP $10,226,622 3,061,863 2.46% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $10,082,117 3,018,598 2.43% Shares
Saba Capital Management, L.P. $9,626,444 2,882,169 2.32% Shares
Owl Creek Asset Management, L.P. $8,452,277 2,530,622 2.04% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8,176,380 2,448,018 1.97% Shares
DIMENSIONAL FUND ADVISORS LP $7,854,253 2,351,460 1.89% Shares
D. E. Shaw & Co., Inc. $7,829,388 2,344,128 1.89% Shares
AQR CAPITAL MANAGEMENT LLC $7,651,362 2,290,827 1.84% Shares
TWO SIGMA INVESTMENTS, LP $7,365,822 2,205,336 1.77% Shares
Diameter Capital Partners LP $6,138,793 1,837,962 1.48% Shares
BANK OF AMERICA CORP /DE/ $5,903,847 1,767,619 1.42% Shares
GOLDMAN SACHS GROUP INC $5,868,073 1,756,908 1.41% Shares
TWO SIGMA ADVISERS, LP $5,816,476 1,864,255 1.40% Shares
CARRONADE CAPITAL MANAGEMENT, LP $5,230,000 1,565,847 1.26% Shares
Allianz Asset Management GmbH $5,167,919 1,547,281 1.24% Shares
MORGAN STANLEY $4,800,489 1,437,272 1.16% Shares
NORTHERN TRUST CORP $4,681,414 1,401,621 1.13% Shares
Silver Rock Financial LP $3,674,000 1,100,000 0.89% Shares
CITADEL ADVISORS LLC $3,475,360 1,040,527 0.84% Shares
Assenagon Asset Management S.A. $2,788,275 834,813 0.67% Shares
VANGUARD FIDUCIARY TRUST CO $2,642,231 791,087 0.64% Shares
Jefferies Financial Group Inc. $2,481,286 742,900 0.60% Shares
Alta Fundamental Advisers LLC $2,161,411 647,129 0.52% Shares
Bank of New York Mellon Corp $2,122,084 635,354 0.51% Shares
MARSHALL WACE, LLP $1,906,575 570,831 0.46% Shares
MILLENNIUM MANAGEMENT LLC $1,701,580 509,455 0.41% Shares
ExodusPoint Capital Management, LP $1,664,603 498,384 0.40% Shares
READYSTATE ASSET MANAGEMENT LP $1,657,729 496,326 0.40% Shares
WOLVERINE ASSET MANAGEMENT LLC $1,339,674 401,100 0.32% Call option
Helix Partners Management LP $1,336,000 400,000 0.32% Shares
Susquehanna Portfolio Strategies, LLC $1,280,940 383,515 0.31% Shares
Voleon Capital Management LP $1,247,032 373,363 0.30% Shares
Invesco Ltd. $1,076,599 322,335 0.26% Shares
TUDOR INVESTMENT CORP ET AL $999,388 299,218 0.24% Shares
Pathstone Holdings, LLC $895,621 268,150 0.22% Shares
Prescott Group Capital Management, L.L.C. $863,076 258,406 0.21% Shares
UBS Group AG $851,089 254,817 0.21% Shares
MILLENNIUM MANAGEMENT LLC $835,000 250,000 0.20% Put option
FEDERATED HERMES, INC. $812,599 243,293 0.20% Shares
LPL Financial LLC $737,239 220,730 0.18% Shares
IEQ CAPITAL, LLC $657,963 196,995 0.16% Shares

Show all 196 institutional owners →

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 filings March 11, 2021 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 56 insiders · 29 officers · 23 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Kevin J Hammons CEO March 1, 2026 A 895,545 0 0 $0
Tim Hingtgen CEO March 1, 2025 A 1,388,781 0 0 $0
Jason K Johnson EVP & CFO March 1, 2026 A 268,439 0 0 $0
Thomas J Aaron EVP and CFO Dec. 7, 2019 F 241,515 0 0 $0
Larry W Cash President and CFO March 1, 2017 A 568,152 0 0 $0
Miguel S Benet President and CMO March 1, 2025 D 47,635 0 0 $0
Austen D Mason Regional President March 1, 2025 A 142,500 0 0 $0
Mark B Medley Regional President March 1, 2025 A 128,637 0 0 $0
Chad A Campbell Regional President March 1, 2025 A 136,815 0 0 $0
Charles J Cova Regional President March 1, 2024 A 58,701 0 0 $0
Lynn T Simon President and CMO March 1, 2024 A 482,657 0 0 $0
Beryl Ramsey Division President March 1, 2019 A 62,969 0 0 $0
Patton Paul Smith Division President March 1, 2019 F 119,017 0 0 $0
Iii John W Mcclellan Division President March 1, 2017 A 41,242 0 0 $0
Robert O Horrar Division President March 1, 2017 A 68,649 0 0 $0
Martin Bonick Division President March 1, 2017 A 100,458 0 0 $0
Michael T Portacci Division President March 1, 2017 A 110,156 0 0 $0
Thomas Daniel Miller Division President March 1, 2016 A 112,107 0 0 $0
David Lewis Miller President and COO March 1, 2016 A 440,840 0 0 $0
William S Hussey Division President Oct. 28, 2015 M 121,568 0 0 $0
Martin Dewayne Smith Division President June 3, 2015 M 94,111 0 0 $0
Gary D Newsome Division President - Group Ops Aug. 25, 2008 M 118,286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO June 1, 2026 A 30,000 0 0 $0
Phillip A. Posey SVP & CAO March 1, 2026 A 51,736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer March 1, 2026 A 287,750 0 0 $0
Kevin A Stockton EVP, Operations & Development March 1, 2026 A 208,290 0 0 $0
Rachel A Seifert Executive VP and Secretary March 1, 2017 F 243,065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer Feb. 25, 2012 F 78,379 0 0 $0
Martin G Schweinhart Senior Vice President March 1, 2006 A 40,354 0 0 $0
William Norris Jennings Director Aug. 25, 2026 S 38,468 0 1 $-118,400
Ranga K Krishnan Director June 30, 2026 M 170,023 0 0 $0
Fawn D Lopez Director March 1, 2026 A · 0 0 $0
Ronald L Burgess JR Director March 1, 2026 A · 0 0 $0
Susan W Brooks Director March 1, 2026 A 108,695 0 0 $0
Hubert James Williams Director March 1, 2026 A 211,863 0 0 $0
Joseph Arthur Hastings Director March 1, 2026 A 0 0 0 $0
Elizabeth T Hirsch Director March 1, 2026 A 162,059 0 0 $0
James S. Ely III Director March 1, 2026 A 412,876 0 0 $0
John A Fry Director March 1, 2026 A 268,966 0 0 $0
John A Clerico Director March 1, 2026 A 368,763 0 0 $0
Michael Dinkins Director March 1, 2026 A 225,882 0 0 $0
Wayne T Smith Director March 1, 2026 A 5,217,579 0 0 $0
Julia B North Director March 1, 2021 A 162,056 0 0 $0
Mitchell H Watson JR Director May 16, 2017 M 22,594 0 0 $0
Harvey Klein MD Director March 15, 2010 M 10,383 0 0 $0
Dale F Frey Director March 31, 2008 A 20,000 0 0 $0
Thomas H Lister Director Sept. 21, 2004 S 0 0 0 $0
Thodore Forstmann Director Sept. 21, 2004 S 0 0 0 $0
Sandra Horbach Director Sept. 21, 2004 S 0 0 0 $0
Robert J Dole Director May 6, 2004 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP 10% owner Sept. 21, 2004 S 0 0 0 $0
FLC XXX PARTNERSHIP LP 10% owner Sept. 21, 2004 S 0 0 0 $0
Winston Hutchins 10% owner Sept. 21, 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP 10% owner Sept. 21, 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P 10% owner Sept. 21, 2004 S 0 0 0 $0
Benjamin C Fordham · March 1, 2021 A 254,608 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 25 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
BSJR · Invesco Exchange-Traded Self-Indexe… 2.85% 24,817,000 Oct. 2, 2026 Daily
EBIT · Harbor ETF Trust 0.45% 19,210 NS July 31, 2026 N-PORT
IWC · iShares Trust 0.09% 443,690 SH Sept. 11, 2026 Daily
IHF · iShares Trust 0.05% 223,947 SH Sept. 11, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.03% 113,109 SH Aug. 19, 2026 Daily
NEAR · iShares U.S. ETF Trust 0.03% 1,340,000 SH Sept. 11, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.02% 221,871 SH Oct. 2, 2026 Daily
IWM · iShares Trust 0.01% 3,425,206 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.01% 62,038 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 746,733 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.01% 349,881 SH Aug. 19, 2026 Daily
DFAS · Dimensional ETF Trust 0.01% 289,348 NS July 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.00% 202,789 NS July 31, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.00% 33,838 NS July 31, 2026 N-PORT
ITOT · iShares Trust 0.00% 203,848 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 42,177 SH Sept. 3, 2026 Daily
DCOR · Dimensional ETF Trust 0.00% 6,184 NS July 31, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.00% 31,135 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 1,347,195 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 3,813,888 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 9,817 SH Aug. 19, 2026 Daily
DFSU · Dimensional ETF Trust 0.00% 24 NS July 31, 2026 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… · · July 15, 2026 Daily
VPLS · VANGUARD MALVERN FUNDS · · July 15, 2026 Daily
IWN · iShares Trust · 1,223,127 SH Sept. 11, 2026 Daily

CYH Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 16 analysts HOLD
Median target $3.12 +14.9%
1 6.2% Strong Buy
1 6.2% Buy
6 37.5% Hold
7 43.8% Sell
1 6.2% Strong Sell

12-Month Price Target

8 analysts · 2026-10-01

Mean target $3.16 +16.0%

Now Current price $2.72
Low$2.00 Mean$3.16 High$4.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

Latest News Recent headlines mentioning this company

23

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Jul 23, 2026